Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: RE: WHY ???????????????

RE: WHY ???????????????

posted on Sep 17, 2006 09:04AM
Simple…Precedence. AMD (5.9B Annual Revenue) & INTC (37.0B Annual Revenue) got off pretty cheap…I think we would all agree. Annual revenues for FSL are 6B, so when considering a buyout of the magnitude (17B), I seriously doubt that a settlement payment of 3X, 4X, or even 5X what AMD or INTC paid would even be a concern for them when making the offer to buyout FSL. I know Blackstone and their partners well, and have been in on the DD they perform, and one thing I know…they are good and don’t make mistakes. GLTAL
Share
New Message
Please login to post a reply